2009
DOI: 10.1016/j.fertnstert.2008.12.079
|View full text |Cite
|
Sign up to set email alerts
|

An estrogen treatment may reverse a premature ovarian failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 1 publication
0
3
0
Order By: Relevance
“…In 5-10% of cases of POI, however, pregnancy can occur naturally, with hormone replacement therapy (HRT), IVF, or, more recently, in-vitro maturation (IVM) or with stem cell therapy . Numerous case reports also support this statement (TABLE 1) (Check et al, 2000;Nawroth et al, 2000;Zargar et al, 2000;Takahashi et al, 2001;Fernandes, 2002;Hershlag and Schuster 2002;Chao et al, 2003;Eldeen and Fawzi, 2003;Muller et al, 2003;Patel et al, 2003;Aslam et al, 2004;Menezo et al, 2004;Vital-Reyes et al, 2004;Corrigan et al, 2005;Check and Katsoff, 2006;Vandborg and Lauszus, 2006;Liza et al, 2008;Dragojevic-Dikic et al, 2009;Genazzani, 2009;Neves-e-Castro, 2009;Selvaraj et al, 2010;Chen and Chen, 2011;Ebrahimi et al, 2011, Ferrau et al, 2011Laway et al, 2011;Tartagni et al, 2011;Ghazeeri and Awwad, 2012;Grynberg et al, 2013;Maruyama et al, 2013;Soave et al, 2013;Tsuji et al, 2013;Rogenhofer et al, 2014;Warenik-Szymankiewicz and Slopien 2014;Roth and Alvero, 2014;Li et al, 2016).…”
mentioning
confidence: 89%
“…In 5-10% of cases of POI, however, pregnancy can occur naturally, with hormone replacement therapy (HRT), IVF, or, more recently, in-vitro maturation (IVM) or with stem cell therapy . Numerous case reports also support this statement (TABLE 1) (Check et al, 2000;Nawroth et al, 2000;Zargar et al, 2000;Takahashi et al, 2001;Fernandes, 2002;Hershlag and Schuster 2002;Chao et al, 2003;Eldeen and Fawzi, 2003;Muller et al, 2003;Patel et al, 2003;Aslam et al, 2004;Menezo et al, 2004;Vital-Reyes et al, 2004;Corrigan et al, 2005;Check and Katsoff, 2006;Vandborg and Lauszus, 2006;Liza et al, 2008;Dragojevic-Dikic et al, 2009;Genazzani, 2009;Neves-e-Castro, 2009;Selvaraj et al, 2010;Chen and Chen, 2011;Ebrahimi et al, 2011, Ferrau et al, 2011Laway et al, 2011;Tartagni et al, 2011;Ghazeeri and Awwad, 2012;Grynberg et al, 2013;Maruyama et al, 2013;Soave et al, 2013;Tsuji et al, 2013;Rogenhofer et al, 2014;Warenik-Szymankiewicz and Slopien 2014;Roth and Alvero, 2014;Li et al, 2016).…”
mentioning
confidence: 89%
“…We think that this case report may suggest, together with previous demonstrations [18], that estro-progestin treatment might be proven in POI women, even in cases with highly elevated gonadotropin serum levels, before telling them that they are definitely sterile.…”
Section: Discussionmentioning
confidence: 51%
“…1), but the ovarian responsiveness, as expressed by normal ovarian volume and by ovulatory follicles at ultrasound, as well as by the re-establishment of regular menses after estro-progestin discontinuation, was achieved after 4 years of treatment. In most reported cases the ovulatory response occurs after 2 to 8 months course of estro-progestin therapy [1,17], though 2 years of treatment have been found to be necessary in one case [18]. Indeed, follicle-like structures were demonstrated by ultrasound in earlier follow-up visits (see Table 1), but they weren't likely to demonstrate a functional ovarian activity.…”
Section: Discussionmentioning
confidence: 99%